316 related articles for article (PubMed ID: 25625206)
1. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.
Zhou Z; Rawnsley DR; Goddard LM; Pan W; Cao XJ; Jakus Z; Zheng H; Yang J; Arthur JS; Whitehead KJ; Li D; Zhou B; Garcia BA; Zheng X; Kahn ML
Dev Cell; 2015 Jan; 32(2):168-80. PubMed ID: 25625206
[TBL] [Abstract][Full Text] [Related]
2. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
3. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Cullere X; Plovie E; Bennett PM; MacRae CA; Mayadas TN
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14284-9. PubMed ID: 26540726
[TBL] [Abstract][Full Text] [Related]
4. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.
Choi JP; Wang R; Yang X; Wang X; Wang L; Ting KK; Foley M; Cogger V; Yang Z; Liu F; Han Z; Liu R; Baell J; Zheng X
Sci Adv; 2018 Nov; 4(11):eaau0731. PubMed ID: 30417093
[TBL] [Abstract][Full Text] [Related]
5. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
[TBL] [Abstract][Full Text] [Related]
6. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Ren AA; Snellings DA; Su YS; Hong CC; Castro M; Tang AT; Detter MR; Hobson N; Girard R; Romanos S; Lightle R; Moore T; Shenkar R; Benavides C; Beaman MM; Müller-Fielitz H; Chen M; Mericko P; Yang J; Sung DC; Lawton MT; Ruppert JM; Schwaninger M; Körbelin J; Potente M; Awad IA; Marchuk DA; Kahn ML
Nature; 2021 Jun; 594(7862):271-276. PubMed ID: 33910229
[TBL] [Abstract][Full Text] [Related]
8. Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation.
Yang X; Wu ST; Gao R; Wang R; Wang Y; Dong Z; Wang L; Qi C; Wang X; Schmitz ML; Liu R; Han Z; Wang L; Zheng X
JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36692953
[TBL] [Abstract][Full Text] [Related]
9. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
11. CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway.
Choi JP; Yang X; He S; Song R; Xu ZR; Foley M; Wong JJ; Xu CR; Zheng X
Stroke; 2021 Apr; 52(4):1428-1436. PubMed ID: 33657857
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3.
Wang X; Hou Y; Deng K; Zhang Y; Wang DC; Ding J
Structure; 2015 Jun; 23(6):1087-96. PubMed ID: 25982527
[TBL] [Abstract][Full Text] [Related]
13. MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis.
Deng Y; Yang J; McCarty M; Su B
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1404-11. PubMed ID: 17687003
[TBL] [Abstract][Full Text] [Related]
14. Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex.
Fisher OS; Deng H; Liu D; Zhang Y; Wei R; Deng Y; Zhang F; Louvi A; Turk BE; Boggon TJ; Su B
Nat Commun; 2015 Aug; 6():7937. PubMed ID: 26235885
[TBL] [Abstract][Full Text] [Related]
15. MEKK3 initiates transforming growth factor beta 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesis.
Stevens MV; Broka DM; Parker P; Rogowitz E; Vaillancourt RR; Camenisch TD
Circ Res; 2008 Dec; 103(12):1430-40. PubMed ID: 19008476
[TBL] [Abstract][Full Text] [Related]
16. Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis.
Donat S; Lourenço M; Paolini A; Otten C; Renz M; Abdelilah-Seyfried S
Elife; 2018 Feb; 7():. PubMed ID: 29364115
[TBL] [Abstract][Full Text] [Related]
17. Cerebral cavernous malformations arise independent of the heart of glass receptor.
Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endothelial cell survival and death by the MAP kinase/ERK kinase kinase 3 - glyceraldehyde-3-phosphate dehydrogenase signaling axis.
Li YQ; Ngo A; Hoffmann P; Ferrante A; Hii CS
Cell Signal; 2019 Jun; 58():20-33. PubMed ID: 30831195
[TBL] [Abstract][Full Text] [Related]
19. Endothelial MEKK3-KLF2/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis.
Yang Y; Mumau M; Tober J; Zhu Q; Bennett L; Hong C; Sung D; Keller T; Uzun Y; Gao P; Shewale S; Chen M; Yang J; Chen X; Thomas SA; Tan K; Speck NA; Kahn ML
Blood; 2022 May; 139(19):2942-2957. PubMed ID: 35245372
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic Forces Sculpt Developing Heart Valves through a KLF2-WNT9B Paracrine Signaling Axis.
Goddard LM; Duchemin AL; Ramalingan H; Wu B; Chen M; Bamezai S; Yang J; Li L; Morley MP; Wang T; Scherrer-Crosbie M; Frank DB; Engleka KA; Jameson SC; Morrisey EE; Carroll TJ; Zhou B; Vermot J; Kahn ML
Dev Cell; 2017 Nov; 43(3):274-289.e5. PubMed ID: 29056552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
